Kayne Anderson Rudnick Investment Management LLC Emergent Bio Solutions Inc. Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $3,803 - $6,266	-70 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $819 - $944	16 Added 29.63%	70 $4,000
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $2,155 - $2,908	54 New	54 $3,000

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$33.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$29.3 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21.5 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$19.2 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.5 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $429M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account